Compare Ecolab Inc. (ECL) vs Koninklijke Philips NV (PHG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ecolab Inc. vs Koninklijke Philips NV — how do they compare? Ecolab Inc. trades at $281.83 (market cap $78.97B), while Koninklijke Philips NV trades at $24.24 (market cap $23.52B). The key difference: Ecolab Inc. is far larger — about 3.4× Koninklijke Philips NV's market cap, and Koninklijke Philips NV pays the higher dividend (4.17%). Which is the better fit depends on your goals — on Pluang, investors hold Ecolab Inc. for 90 Days and Koninklijke Philips NV for 84 Days on average.
| ECL | PHG | |
|---|---|---|
Market Cap | $78.97B | $23.52B |
Volume | 974,947 | 1,635,069 |
Sector | Basic Materials | Health |
52-Week High | $308.35 | $32.91 |
52-Week Low | $245.73 | $23.81 |
Typical Hold Time | 90 Days | 84 Days |
Enterprise Value | $87.75B | $29.87B |
Dividend Yield | 1.04% | 4.17% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ECL trades at $281.69, up 1.29% with strong analyst support (78% buy ratings) and a $326.38 consensus target. The stock shows bullish technical momentum above key support at $279, supported by improving fundamentals including 9.7% Q2 sales growth and consistent dividend increases. Recent institutional buying and director purchases signal confidence ahead of Q3 earnings on October 27.
Outlook remains positive with High-Tech and Digital segments driving growth, though elevated P/E of 37.8 and rising debt from the CoolIT acquisition present valuation and execution risks. The dividend aristocrat status and essential service model provide stability, making ECL attractive for long-term investors despite near-term cost pressures.
PHG trades at $24.30, up 0.87% with a bearish technical signal despite three consecutive quarterly earnings beats. The company shows improving fundamentals with net income turning positive at $895 million in 2025 after previous losses, supported by strong operational cash flow of $1.17 billion. Recent developments include new product launches in healthcare technology and a $33.7 million ARPA-H award for AI-enabled stroke care.
While analyst consensus leans Hold (63.64%), the improving profitability trajectory and reasonable valuation (P/E 18.94) present opportunity, though technical weakness and competitive healthcare market risks require monitoring. The stock faces resistance near $25 with support at $24, with institutional ownership showing mixed signals through recent acquisitions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Ecolab Inc.
Ecolab produces and markets cleaning and sanitation products for the hospitality, healthcare, and industrial markets. The firm is the global market share leader in this category with a wide array of products and services, including dish and laundry washing systems, pest control, and infection control products. The company has a strong hold on the U.S. market and is looking to increase its profitability abroad. Additionally, Ecolab serves customers in water, manufacturing, and life sciences end markets, selling customized solutions.
Read more on ECL →About Koninklijke Philips NV
Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.
Read more on PHG →
